Business Description
Nanosphere Health Sciences Inc
NAICS : 325410
SIC : 3741
ISIN : CA63010P1009
Compare
Compare
Traded in other countries / regions
NSHS.Canada2CG2.GermanyNSHSF.USA IPO Date
2018-01-25Description
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -81.04 | |||||
Debt-to-Equity | -0.05 | |||||
Debt-to-EBITDA | -0.76 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 33.8 | |||||
3-Year EPS without NRI Growth Rate | 31.8 | |||||
3-Year FCF Growth Rate | 30.7 | |||||
3-Year Book Growth Rate | -1.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.12 | |||||
9-Day RSI | 52.6 | |||||
14-Day RSI | 53.33 | |||||
3-1 Month Momentum % | 300 | |||||
12-1 Month Momentum % | -23.81 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -550 | |||||
ROIC % | -396.5 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -2.56 | |||||
EV-to-EBITDA | -2.56 | |||||
EV-to-FCF | -10.07 | |||||
Earnings Yield (Greenblatt) % | -39.06 | |||||
FCF Yield % | -13.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanosphere Health Sciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | - | ||
| Beta | 4.9839 | ||
| 3-Year Sharpe Ratio | 0.96 | ||
| 3-Year Sortino Ratio | 3.78 | ||
| Volatility % | 451.69 | ||
| 14-Day RSI | 53.33 | ||
| 14-Day ATR (€) | 0.003717 | ||
| 20-Day SMA (€) | 0.0094 | ||
| 12-1 Month Momentum % | -23.81 | ||
| 52-Week Range (€) | 0.0005 - 0.0655 | ||
| Shares Outstanding (Mil) | 10.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanosphere Health Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanosphere Health Sciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.05:1 Stock Split | 2021-07-07 | 0.30 (+0.00%) |
Show
Entries
Nanosphere Health Sciences Inc Frequently Asked Questions
What is Nanosphere Health Sciences Inc(STU:2CG2)'s stock price today?
The current price of STU:2CG2 is €0.01. The 52 week high of STU:2CG2 is €0.07 and 52 week low is €0.00.
When is next earnings date of Nanosphere Health Sciences Inc(STU:2CG2)?
The next earnings date of Nanosphere Health Sciences Inc(STU:2CG2) is .
Does Nanosphere Health Sciences Inc(STU:2CG2) pay dividends? If so, how much?
Nanosphere Health Sciences Inc(STU:2CG2) does not pay dividend.
Press Release
Articles on Nanosphere Health Sciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers